Dr. Joey Ann England, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6700 West Loop S, Suite 450, Bellaire, TX 77401 Phone: 713-486-9332 Fax: 713-486-9301 |
Dr. Uyen H Ta, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6750 West Loop S, #420, Bellaire, TX 77401 Phone: 281-220-2069 Fax: 281-569-4267 |
Marcel Dwaine Thompson, D.O. Obstetrics & Gynecology - Gynecology Medicare: Medicare Enrolled Practice Location: 4914 Bissonnet St Ste 101, Bellaire, TX 77401 Phone: 713-623-1414 Fax: 713-623-1784 |
Dr. Terri-ann Patricia Samuels, M.D. Obstetrics & Gynecology - Female Pelvic Medicine and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 6750 West Loop S Ste 1060, Bellaire, TX 77401 Phone: 832-831-0362 Fax: 866-313-7527 |
Pamela A Promecene-cook, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6500 West Loop S Ste 200d, Bellaire, TX 77401 Phone: 832-325-7131 Fax: 713-512-2216 |
Dr. Jill C Hutton, MD, MPH Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6706 Ferris St, Bellaire, TX 77401 Phone: 713-714-7523 Fax: 844-321-8477 |
Jerrie S Refuerzo, MD Obstetrics & Gynecology - Maternal & Fetal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6700 West Loop South, Suite 420, Bellaire, TX 77401 Phone: 832-325-7133 Fax: 713-383-1479 |
Pamela D Berens, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6500 West Loop S Ste 200d, Bellaire, TX 77401 Phone: 713-486-9300 Fax: 713-486-9301 |
Dr. Myrtle Oates, M.D. Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6800 West Loop South, Suite 560/580, Bellaire, TX 77401 Phone: 713-844-8035 Fax: 713-844-8037 |
News Archive
The Minister for Health and Ageing, Tony Abbott announced that Australian researchers now have the opportunity to access A$70 million in international research funding each year and to lead international research teams as part of the Human Frontier Science Program.
Animal experiments suggest that taking the omega-3 fatty acid docosahexanoic acid (DHA) might offer a new way of protecting against traumatic brain injury (TBI), reports the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
Robert Jesse, acting undersecretary for health, and Will Gunn, the department's general counsel, will be leaving their positions at the troubled agency.
› Verified 6 days ago